Serum Omentin-1 and Carotid Atherosclerosis In Non-Diabetic Chronic Kidney Disease
This study is currently recruiting participants.
Verified October 2012 by Kocaeli Derince Education and Research Hospital
Sponsor:
Kocaeli Derince Education and Research Hospital
Information provided by (Responsible Party):
Kocaeli Derince Education and Research Hospital
ClinicalTrials.gov Identifier:
NCT01701830
First received: October 3, 2012
Last updated: October 4, 2012
Last verified: October 2012
| Tracking Information | |||||
|---|---|---|---|---|---|
| First Received Date ICMJE | October 3, 2012 | ||||
| Last Updated Date | October 4, 2012 | ||||
| Start Date ICMJE | October 2012 | ||||
| Primary Completion Date | Not Provided | ||||
| Current Primary Outcome Measures ICMJE | Not Provided | ||||
| Original Primary Outcome Measures ICMJE | Not Provided | ||||
| Change History | Complete list of historical versions of study NCT01701830 on ClinicalTrials.gov Archive Site | ||||
| Current Secondary Outcome Measures ICMJE | Not Provided | ||||
| Original Secondary Outcome Measures ICMJE | Not Provided | ||||
| Current Other Outcome Measures ICMJE | Not Provided | ||||
| Original Other Outcome Measures ICMJE | Not Provided | ||||
| Descriptive Information | |||||
| Brief Title ICMJE | Serum Omentin-1 and Carotid Atherosclerosis In Non-Diabetic Chronic Kidney Disease | ||||
| Official Title ICMJE | The Relationship Between Serum Omentin-1 and IL-6 and Carotid Atherosclerosis In Non-Diabetic Chronic Kidney Disease | ||||
| Brief Summary | The aim of the study is to evaluate whether a low level of serum omentin-1 is associated with carotid atherosclerosis and mediated by inflammation. |
||||
| Detailed Description | Atherosclerotic cardiovascular disease is markedly increased in chronic kidney disease. There are a lot of risk factor, along with conventional risk factors. Serum onemtin-1 is a adipokine and suggested as a new marker for vascular disease.It has some anti-atherogenic properties. Studies investigating serum omentin-1 level have usually conducted in patients with diabetes mellitus. |
||||
| Study Type ICMJE | Observational | ||||
| Study Design ICMJE | Observational Model: Case Control Time Perspective: Cross-Sectional |
||||
| Target Follow-Up Duration | Not Provided | ||||
| Biospecimen | Not Provided | ||||
| Sampling Method | Non-Probability Sample | ||||
| Study Population | Department of Nephrology, Check-up clinic |
||||
| Condition ICMJE |
|
||||
| Intervention ICMJE | Not Provided | ||||
| Study Group/Cohort (s) |
|
||||
| Publications * | Not Provided | ||||
|
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. |
|||||
| Recruitment Information | |||||
| Recruitment Status ICMJE | Recruiting | ||||
| Estimated Enrollment ICMJE | 85 | ||||
| Estimated Completion Date | May 2013 | ||||
| Primary Completion Date | Not Provided | ||||
| Eligibility Criteria ICMJE | Inclusion Criteria:
Exclusion Criteria:
|
||||
| Gender | Both | ||||
| Ages | 18 Years to 75 Years | ||||
| Accepts Healthy Volunteers | Yes | ||||
| Contacts ICMJE | Not Provided | ||||
| Location Countries ICMJE | Turkey | ||||
| Administrative Information | |||||
| NCT Number ICMJE | NCT01701830 | ||||
| Other Study ID Numbers ICMJE | 2012/02 | ||||
| Has Data Monitoring Committee | Not Provided | ||||
| Responsible Party | Kocaeli Derince Education and Research Hospital | ||||
| Study Sponsor ICMJE | Kocaeli Derince Education and Research Hospital | ||||
| Collaborators ICMJE | Not Provided | ||||
| Investigators ICMJE |
|
||||
| Information Provided By | Kocaeli Derince Education and Research Hospital | ||||
| Verification Date | October 2012 | ||||
|
ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP |
|||||